Literature DB >> 18005734

An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Stuart J D Neil1, Virginie Sandrin, Wesley I Sundquist, Paul D Bieniasz.   

Abstract

Type 1 interferon (IFN) inhibits the release of HIV-1 virus particles via poorly defined mechanisms. Here, we show that IFNalpha induces retention of viral particles on the surface of fibroblasts, T cells, or primary lymphocytes infected with HIV-1 lacking the Vpu protein. Retained particles are tethered to cell surfaces, can be endocytosed, appear fully assembled, exhibit mature morphology, and can be detached by protease. Strikingly, expression of the HIV-1 Vpu protein attenuates the ability of human cells to adhere to, and thereby retain, nascent HIV-1 particles upon IFNalpha treatment. Vpu also counteracts the IFNalpha-induced retention of virus-like particles assembled from the Ebola virus matrix protein. Furthermore, levels of IFNalpha that suppress replication of Vpu-defective HIV-1 have little effect on wild-type HIV-1. Thus, we propose that HIV-1 expresses Vpu to counteract an IFNalpha-induced, general host defense that inhibits dissemination of enveloped virions from the surface of infected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005734      PMCID: PMC3793644          DOI: 10.1016/j.chom.2007.08.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  43 in total

Review 1.  Retrovirus restriction factors.

Authors:  Stephen P Goff
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

2.  Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Authors:  Paolo Abada; Beth Noble; Paula M Cannon
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.

Authors:  J Lama; A Mangasarian; D Trono
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

4.  Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.

Authors:  T M Ross; A E Oran; B R Cullen
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

5.  Structure-function relationship of the small GTPase rab5.

Authors:  G Li; P D Stahl
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

6.  Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.

Authors:  Y Shirazi; P M Pitha
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

7.  Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses.

Authors:  H G Göttlinger; T Dorfman; E A Cohen; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.

Authors:  Y Shirazi; P M Pitha
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis.

Authors:  H Stenmark; R G Parton; O Steele-Mortimer; A Lütcke; J Gruenberg; M Zerial
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

10.  Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

Authors:  P Biswas; G Poli; A L Kinter; J S Justement; S K Stanley; W J Maury; P Bressler; J M Orenstein; A S Fauci
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  158 in total

1.  Budding capability of the influenza virus neuraminidase can be modulated by tetherin.

Authors:  Mark A Yondola; Fiona Fernandes; Alan Belicha-Villanueva; Melissa Uccelini; Qinshan Gao; Carol Carter; Peter Palese
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

2.  Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.

Authors:  Isabelle Dietrich; Elizabeth L McMonagle; Sarah J Petit; Swetha Vijayakrishnan; Nicola Logan; Chi N Chan; Greg J Towers; Margaret J Hosie; Brian J Willett
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.

Authors:  Nolwenn Jouvenet; Stuart J D Neil; Maria Zhadina; Trinity Zang; Zerina Kratovac; Youngnam Lee; Matthew McNatt; Theodora Hatziioannou; Paul D Bieniasz
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

4.  Inhibition of Lassa and Marburg virus production by tetherin.

Authors:  Toshie Sakuma; Takeshi Noda; Shuzo Urata; Yoshihiro Kawaoka; Jiro Yasuda
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

Review 5.  Host restriction factors blocking retroviral replication.

Authors:  Daniel Wolf; Stephen P Goff
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

6.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

7.  A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins.

Authors:  Gajendra W Suryawanshi; Alexander Hoffmann
Journal:  J Theor Biol       Date:  2015-09-16       Impact factor: 2.691

8.  Regulation of porcine endogenous retrovirus release by porcine and human tetherins.

Authors:  Giada Mattiuzzo; Sabrina Ivol; Yasuhiro Takeuchi
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 9.  Accessories to the crime: recent advances in HIV accessory protein biology.

Authors:  Thomas Gramberg; Nicole Sunseri; Nathaniel R Landau
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

10.  Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

Authors:  Janet L Douglas; Kasinath Viswanathan; Matthew N McCarroll; Jean K Gustin; Klaus Früh; Ashlee V Moses
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.